Tytuł artykułu
Autorzy
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
Combretastatin A-4 is a potent antineoplastic and antiangiogenesis natural substance isolated from the South African treeCombretum caffrum. This article concerns synthesis and biological activity of combretastatin A-4 and its analogues which are considered as prodrugs.
Wydawca
Czasopismo
Rocznik
Tom
Strony
323--341
Opis fizyczny
Bibliogr. 64 poz., rys.
Twórcy
autor
- Department of Organic Chemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Street, 80-952 Gdańsk, Poland
autor
- Department of Organic Chemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Street, 80-952 Gdańsk, Poland
Bibliografia
- 1. Folkman J„ N. Engl. J. Med., 285, 1182 (1971).
- 2. O’Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R. and Folkamn J., Cell, 88, 277 (1997).
- 3. Harris A.L., Lancet, 351, 1598 (1998).
- 4. Gourley M. and Williamson J.S., Curr. Pharmacol Design, 6,417 (2000).
- 5. Aiello L.P., Nature Med., 6, 379 (2000).
- 6. Liekens S., De Clercq E. and Neyts J., Biochemical Pharmacology, 61, 253 (2001).
- 7. Opolski A. and Wietrzyk J., Post. Hig. Med. Dosw., 55, 369 (2001).
- 8. Rowinsky E.K., Donehower R.C., In Cancer, Principle and Practice of Oncology, 5 th ed.; DeVita V.T., Jr, Heilman S., Rosenberg S.A., eds.: Lippincott-Raven: Philadelphia, pp. 467-483 (1997).
- 9.Iwasaki S., J. Pharmacol. Soc. Jpn., 118, 111 (1998).
- 10. Li Q., Sham H.L., Rosenberg S.H., Antimitotic Agents. In Annual Reports in Medicinal Chemistry, Doherty A.M., Ed.; Academic Press: San Diego, Vol. 34, pp. 139-148 (1999).
- 11. Shi Q., Chen K., Morris-Natschke S.L. and Lee K.H., Curr. Pharm. Des., 4, 219 (1998).
- 12. Jordan A., Hadfield J.A., Laurence N.J. and McGown A.T., Med. Chem. Rev., 18, 259 (1998).
- 13. Pettit G.R., Singh S.B., Niven M.L., Hamel E. and Schmidt J.M.,/ of Natural Products, 50,119 (1987).
- 14. Pettit G.R. and Singh S.B., Can. J. Chem., 65, 2390 (1987).
- 15. Pettit G.R., Singh S.B., Hamel E., Lin C.M., Alberts D.S. and Garcia-Kendall D., Experientia, 45,209 (1989).
- 16. Pettit G.R., Singh S.B. and Cragg G.M., J Org. Chem., 50, 3404(1985).
- 17. Singh S.B. and Pettit G.R., J. Org. Chem., 54, 4105 (1989).
- 18. Pettit G.R., Singh S.B., Boyd M.R., Hamel E., Pettit R.K., Schmidt J.M. and Hogan F,,J. Med. Chem., 38, 1666(1995).
- 19. Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi K., Suga Y., Akiyama Y. and Tsuji l.,J. Med. Chem., 41, 3022 (1998).
- 20. Brown R.T., Fox B.W., Hadfield J.A., McGown A.T., Mayalarp S.P., Pettit G.R. and Woods J.A., J. Chem. Soc. Perkin Trans. 1, 5, 577 (1995).
- 21. Woods J.A., Hadfield J.A., Pettit G.R., Fox B.W. and McGown A.T., Br. J. Cancer, 71, 705 (1995).
- 22. Bedford S.B., Quarterman C.P., Rathbone D.L., Slack J.A., Griffin B.J. and Stevens M.F.G., Bioorg. Med. Chem. Lett., 6, 157 (1996).
- 23. Pettit G.R., Temple C., Jr, Narayanan V.L., Varma R., Simpson M.J., Boyd M.R., Rener G.A. and Bansal N., Anti-Cancer Drug Design, 10,299 (1995).
- 24. Chaplin D.J., Pettit G.R. and Hill S.A., Anticancer Res., 19, 189 (1999).
- 25. Dziba J.M., Marcinek R., Venkataraman G., Robinson J.A. and Ain K.B., Thyroid, 12, 1063 (2002).
- 26. Hua J., Sheng Y., Pinney K.G., Gamer C.M., Kane R.R., Prezioso J.A., Pettit G.R, Chaplin D.J. and Edvardsen K., Anticancer Res., 23, 1433 (2003).
- 27. Pettit G.R. and Rhodes M.R., Anti-Cancer Drug Design, 13, 183 (1998).
- 28. Kerekes P., Sharma P.N., Brossi A., Chignell C.F. and Quinn F.R, J. Med. Chem., 28, 1204 (1985).
- 29. Dumont R, Brossi A., Chignell C.R, Quinn RR. and Suffness M.A., J. Med. Chem., 30, 732 (1987).
- 30. Hamel E., Ho H.H., Kang G.J. and Lin C.M., Biochem. Pharmacol., 37, 2445 (1988).
- 31. Muzaffar A., Brossi A., Lin C.M. and Hamel E., J. Med. Chem., 33, 567 (1990).
- 32. Zavala R, Guenard D., Robin J.P. and Brown E,,J. Med. Chem., 23, 546 (1980).
- 33. Van der Eycken J., Bosnians J.P., Van Haver D., Vandewalle M., Hulkenberg A.,Veerman W. and Nieuwenhuizen R., Tetrahedron Lett., 30, 3873 (1989).
- 34. Klein L.L., Yeung C.M., Chu D.T., McDonald E.J., Clementy J.J. and Plattner J.J., J. Med. Chem., 34, 984 (1991).
- 35. Wang R.W.J., Rebhun L.I. and Kupchan S.M., Cancer Res., 37, 3071 (1977).
- 36. Tomioka K., Ishiguro T., Mizuguchi H., Komeshima N., Koga K., Tsukagoshi S., Tsuruo T., Tashiro T., Tanida S. and Kishi T„ J. Med. Chem., 34, 54 (1991).
- 37. Itoh Y., Brossi A., Hamel E. and Lin C.M., Helv. Chim. Acta, 71, 1199 (1988).
- 38. Batra J.K, Jurd L. and Hamel E., Mol. Pharmacol, 27, 94 (1985).
- 39. Batra J.K., Kang G.J., Jurd L. and Hamel E., Biochem. Pharmacol., 37,2595 (1988).
- 40. Edwards M.L., Stemerick D.M. and Sunkara P.S., J. Med. Chem., 33, 1948 (1990).
- 41. Lin C.M., Singh S.B., Chu P.S., Dempcy R.O., Schmidt J.M., Pettit GR. and Hamel E., Mol. Pharmacol., 34, 200(1988).
- 42. Cushman M., Nagarathnam D., Gopal D., Chakraborti A.K., Lin Ch.M. and Hamel E., J. Med. Chem., 34, 2579(1991).
- 43. Cushman M., Nagarathnam D., Gopal D., Hu-Ming He., Lin Ch.M. and Hamel E., J. Med. Chem., 35, 2293(1992).
- 44. Xia Y., Yang Z.Y., Xia P., Bastow K.R, Tachibana Y., Kuo S.Ch., Hamel E., Hackl T. and Lee K.H., J. Med. Chem., 41, 1155 (1998).
- 45. Ohsumi K., Hatanaka T., Fujita K., Nakagawa R., Fukuda Y., Niher Y., Suga Y., Morinaga Y., Akiyama Y. and Tsuji T., Bioorg. Med. Chem. Lett., 8, 3153 (1998).
- 46. Shirai R., Takayama H., Nishikawa A., Koiso Y. and Hashimoto Y., Bioorg. Med. Chem. Lett., 8, 1997 (1998).
- 47. Medarde M., Ramos A.C., Caballero E., de Clairac R.P.L., Lopez J.L., Gravalos D.G. and Feliciano A.S., Bioorg. Med. Chem. Lett., 9,2303 (1999).
- 48. Gwaltney S.L., Imade H.M., Barr K.J., Li Q., Gehrke L., Credo R.B., Warner R.B., Lee J.Y., Kovar P., Wang J.,NukkalaM.A., Zielinski N.A., Frost D.,NgS.C. and Sham H.L., Bioorg. Med. Chem. Lett., 11, 871 (2001).
- 49. Wang L., Woods K.W., Li Q., Barr K.J., McCroskey R.W., Hannick S.M., Gherke L., Credo R.B., Hui Y.H., Marsh K., Warner R., Lee J.Y., Zielinski-Mozng N., Frost D., Rosenberg S.H. and Sham H.L., J. Med. Chem., 45, 1697 (2002).
- 50. Orsini F., Pelizzoni F., Bellini B. and Miglierini G., Carbohydr. Res., 301, 95 (1997).
- 51. Lawrence N.J., Ghani F.A., Hepworth L.A., Hadfield J.A., McGown A.T. and Pritchard R.G., Synthesis, 1656(1999).
- 52. Furstner A. and Nikolakis K., Liebigs Ann. Chem., 2107 (1996).
- 53. Gaukroger K., Hadfield J.A., Hepworth L. A., Lawrence N.J. and McGown A.T., J. Org. Chem., 66,8135 (2001).
- 54. Pettit G.R., Lippert J.W., Herald D.L., Hamel E. and Pettit R.K., J. Nat. Prod., 63, 969 (2000).
- 55. Dark G.G., Hill S. A., Prise V.E., Tozer G.M., Pettit G.R. and Chaplin D.J., Cancer Res., 57,1829 (1997).
- 56. Lin C.M., Ho H.H., Pettit G.R. and Hamel E., Biochemistry, 28, 6984 (1989).
- 57. Pettit G.R., Toki B., Herald D.L., Verdier-Pinard P., Boyd M.R. and Hamel E., J Med. Chem.,41, 1688 (1998).
- 58. Iyer S., Chaplin D. J., Rosenthal D.S., Boulares A.H., Li L.Y. and Smulson M.E., Cancer Res., 58,4510 (1998).
- 59. DarkG.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R. and Chaplin D.J., Cancer Res., 57,1829.(1997).
- 60. Tozer G.M., Prise V.E., Wilson J., Locke R.J., Vojnovic B., Stratford M.R., Dennis M.F. and Chaplin D.J., Cancer Res., 59, 1626 (1999).
- 61. Dzierzbicka K., Kotodziejczyk A.M., Wysocka-Skrzela B., Mysliwski A. and Sosnowska D., J. Med. Chem., 44, 3606(2001).
- 62. Sosnowska D., Myiliwski A., Dzierzbicka K. and Kolodziejczyk A., Biotherapy, 10, 161 (1997).
- 63. Dzierzbicka K. and Kołdziejczyk A.M., J. Med. Chem., 46, 183 (2003).
- 64. Dzierzbicka K., Trzonkowski P., Sewerynek P. and Myśliwski A., J. Med. Chem., 46, 978 (2003).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ1-0023-0178